Our previous mouse model and in vitro studies revealed that PRMT6 exerts a negative effect on CS-induced pulmonary inflammation through H3R2me2a, while overexpression of PRMT6 inhibits CS-induced inflammation [51, 52]. This evidence concerns the gene PRMT6 and inflammation.